162713-88-4

Basic information

• Product Name: 1H-INDENE-1-ACETIC ACID, 2,3-DIHYDRO-5-METHOXY-, ETHYL ESTER
• Synonyms: 1H-INDENE-1-ACETIC ACID, 2,3-DIHYDRO-5-METHOXY-, ETHYL ESTER;Ethyl 2-(5-Methoxy-2,3-dihydro-1H-inden-1-yl)acetate
• CAS NO: 162713-88-4
• Molecular Formula: C₁₄H₁₈O₃
• Molecular Weight: 234.29
• Mol File: 162713-88-4.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 335.3±35.0 °C(Predicted)
• Appearance: /
• Density: 1.081±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1H-INDENE-1-ACETIC ACID, 2,3-DIHYDRO-5-METHOXY-, ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-INDENE-1-ACETIC ACID, 2,3-DIHYDRO-5-METHOXY-, ETHYL ESTER(162713-88-4)
• EPA Substance Registry System: 1H-INDENE-1-ACETIC ACID, 2,3-DIHYDRO-5-METHOXY-, ETHYL ESTER(162713-88-4)

Safety Data

• Hazardous Substances Data: 162713-88-4(Hazardous Substances Data)

Usage

Ethyl ester derivative

1H-indene-1-acetic acid The compound is derived from 1H-indene-1-acetic acid, which is a naturally occurring indole acetic acid (IAA) auxin hormone found in plants.

Naturally occurring

Indole acetic acid (IAA) auxin hormone This compound is a naturally occurring plant hormone that plays a crucial role in plant growth and development.

Research and development

Starting material 1H-indene-1-acetic acid, 2,3-dihydro-5-methoxy-, ethyl ester is commonly used as a starting material in the synthesis of various pharmaceutical and biologically active compounds.

Ethyl ester form

Stability and ease of handling The ethyl ester form of the compound is often preferred in laboratory applications due to its stability and ease of handling, making it a more convenient option for researchers.

Upstream product

• 73809-30-0 ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate 
• 5111-70-6 5-methoxy-1-indanone 
• 867-13-0 diethoxyphosphoryl-acetic acid ethyl ester 
• 21779-34-0 ethyl 2-[(1E)-5-methoxy-2,3-dihydro-1H-inden-1-ylidene]acetate 

Downstream Products

• 1027420-07-0 (5-{3-[4-(4-tert-butyl-thiazol-2-yl)-2-propyl-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 1026373-63-6 (5-{3-[2-methoxy-4-(4-trifluoromethyl-thiazol-2-yl)-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 1026030-90-9 (5-{3-[4-(4-ethoxy-5-methyl-thiazol-2-yl)-2-propyl-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 1026570-52-4 (5-{3-[4-(4-ethoxy-5-ethyl-thiazol-2-yl)-2-methoxy-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 1027605-30-6 (5-{3-[4-(5-dimethylcarbamoyl-4-methyl-thiazol-2-yl)-2-methoxy-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 1026124-03-7 (5-{3-[4-(5-acetyl-4-methyl-thiazol-2-yl)-2-propyl-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 1026423-85-7 (5-{3-[2-propyl-4-(4-trifluoromethyl-thiazol-2-yl)-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 1026839-76-8 (5-{3-[4-(5-dimethylcarbamoyl-4-methyl-thiazol-2-yl)-2-propyl-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 162713-90-8 <3(1''S),4R>-3-<2'-(5''-methoxy-1''-indanyl)acetyl>-4-(phenylmethyl)-2-oxazolidinone 
• 724467-27-0 ethyl ((1S)-5-{3-[4-(4-ethyl-1,3-thiazol-2-yl)-2-propylphenoxy]propoxy}-2,3-dihydro-1H-inden-1-yl)acetate 
• 1026949-03-0 (5-{3-[4-(4-ethoxy-5-methyl-thiazol-2-yl)-2-methoxy-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 1025831-61-1 (5-{3-[4-(4-ethoxy-thiazol-2-yl)-2-propyl-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 
• 1026465-65-5 (5-{3-[2-methyl-4-(3-trifluoromethyl-[1,2,4]thiadiazol-5-yl)-phenoxy]-propoxy}-indan-1-yl)-acetic acid ethyl ester 

Relevant articles and documents

Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors

Inhibitors of specific src homology 2 (SH2) domain binding interactions could potentially afford new therapeutic approaches toward a variety of diseases, including several cancers. To date SH2 domain inhibitors have been confined to small phosphotyrosyl (

METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES BASED ON APOE4 GENOTYPE

The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders based on the ApoE4 genotype of human subjects.

Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) as follows: wherein R1, G, and Q are defined herein.

GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES

Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR120 receptor. Such compounds are represented by Formula (I) and Formula (II) as follows: wherein Y, R1, G, and Q are defined herein; and wherein R11, R21, R41, RB1 and G1, are defined herein.